Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

medac GmbH
Fehlandtstrasse 3, 20354 Hamburg, Germany
Telephone: +44 (0)1786 458086
Fax: +44 (0)1786 458032
Medical Information e-mail: info@medac-uk.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 01/06/2011
SPC Dacarbazine 100mg, 200mg, 500mg, 1000mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of SPC
Date of revision of text on the SPC:   28-Sep-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Renewal of MA
Updated on 18/09/2008 and displayed until 01/06/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Improved Electronic Presentation
Date of revision of text on the SPC:   20-Nov-2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
None provided
Updated on 11/09/2007 and displayed until 18/09/2008
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   11/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Addition of rare cases of "veno-occlusive disease" to adverse effects.
Updated on 29/09/2005 and displayed until 11/09/2007
Reasons for adding or updating:
  • Change to section 6. 6 - Instruction for Use/Handling
Updated on 16/07/2001 and displayed until 29/09/2005
Reasons for adding or updating:
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 06/09/1999 and displayed until 16/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  dacarbazine citrate